Tocilizumab overcomes chemotherapy resistance in mesenchymal stem-like breast cancer by negating autocrine IL-1A induction of IL-6
托珠单抗通过抑制自分泌 IL-1A 诱导 IL-6 来克服间充质干细胞样乳腺癌的化疗耐药性
期刊:NPJ Breast Cancer
影响因子:6.5
doi:10.1038/s41523-021-00371-0
Andrew W Chung, Anthony J Kozielski, Wei Qian, Jianying Zhou, Ann C Anselme, Alfred A Chan, Ping-Ying Pan, Delphine J Lee, Jenny C Chang
发育与干细胞
肿瘤
乳腺癌
干细胞
ELISA
WB
Mouse
IL-6